Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2010 066 431.7 |
96 | EP file number | EAKZ | 15 20 3085.4 |
97 | EP publication number | EPN | 3167897 |
54 | Designation/title | TI | STABILISIERTE UND LYOPHILISIERTE FLÜSSIGE ZUSAMMENSETZUNGEN VON ADAMTS13 |
51 | IPC main class | ICM (ICMV) | A61K 38/48 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 9/08 (2006.01), A61K 9/19 (2006.01), A61K 47/02 (2006.01), A61K 47/10 (2006.01), A61K 47/18 (2006.01) |
22 | DE application date | DAT | Sep 21, 2010 |
96 | EP application date | EAT | Sep 21, 2010 |
43 | Date of first publication | OT | May 17, 2017 |
| Date of publication of grant | PET | Jan 27, 2021 |
71/73 | Applicant/owner | INH | Takeda Pharmaceutical Company Limited, Osaka-shi, JP |
72 | Inventor | IN | MATTHIESSEN, H., Peter, 1020 Vienna, AT; TURECEK, Peter, L., 3400 Klosterneuburg, AT; Schwarz, Hans-Peter, 1180 Vienna, AT |
74 | Representative | VTR | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
| Address for service | | HOFFMANN - EITLE Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 244353 P Sep 21, 2009
|
| Due date | FT FG | Sep 30, 2025 Annual fee for the 16th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003167897A1 Searchable text:
EP000003167897A1 Original document:
EP000003167897B1 Searchable text:
EP000003167897B1 |
43 | Date of first publication | EVT | May 17, 2017 |
| Date of the first transfer into DPMAregister | EREGT | May 18, 2017 |
| Date of the (most recent) update in DPMAregister | REGT | Nov 12, 2024 (Show all update days)(Hide all update days)- Nov 12, 2024
- Aug 28, 2024
- May 9, 2024; Sep 6, 2023; May 4, 2023; Mar 28, 2023; Aug 27, 2022; Jan 20, 2022; Dec 16, 2021; Aug 25, 2021; Apr 10, 2021; Feb 19, 2021; Jan 8, 2021; Jan 7, 2021; Jan 2, 2020
- Historical data not available for this/these date(s)
- May 18, 2017
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 6)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Mar 27, 2023 |
| Issue number | HN | 18 |
| Year | PJ | 2023 |
| Publication date | VT | May 4, 2023 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Takeda Pharmaceutical Company Limited, Osaka-shi, JP |
71/73 | Previous applicant/owner | INHF | Baxalta GmbH, Glattpark, (Opfikon), CH, Baxalta Incorporated, Bannockburn, Ill., US |
| Date of update of the procedure | REGT | May 4, 2023 |